References
- Ohri SK, Rutty G, Fountain SW. Acquired segmental emphysema: the enlarging spectrum of Swyer-James/Macleod’s syndrome. The Annals of thoracic surgery. 1993;56(1): 120–124.
- Lucaya J, Gartner S, García-Peña P, Cobos N, Roca I, Liñan S. Spectrum of manifestations of Swyer-James- MacLeod syndrome. Journal of Computer Assisted Tomography1998;22(4): 592–597.
- Macleod WM. Abnormal transradiancy of one lung. Thorax. 1954;9(2): 147–153.
- Swyer Pr, James Gc. A case of unilateral pulmonary emphysema. Thorax. 1953;8(2): 133–136.
- Sen HS, Taylan M, Abakay O, Sezgi C, Cetincakmak MG. Adult diagnosis of Swyer-James-Macleod syndrome: retrospective analysis of four cases. Respiratory Care. 2014;59(4): e51–e54.
- Dirweesh A, Alvarez C, Khan M, Shah N. A unilateral hyperlu-cent lung - Swyer-James syndrome: a case report and literature review. Respiratory Medicine Case Reports. 2017;20: 104–106.
- Sulaiman A, Cavaille A, Vaunois B, Tiffet O. Swyer-James- MacLeod syndrome; repeated chest drainages in a patient misdiagnosed with pneumothorax. Interactive Cardiovascular and Thoracic Surgery. 2009;8(4): 482–484.
- O’Dell CW, Taylor A, Higgins CB, Ashburn WL, Schillaci RF, Alazraki NP. Ventilation-perfusion lung images in the Swyer-James syndrome. Radiology. 1976;121(2): 423–426.
- Cumming GR, Macpherson RI, Chernick V. Unilateral hyperlucent lung syndrome in children. The Journal of Pediatrics. 1971;78(2): 250–260.
- Stokes D, Sigler A, Khouri NF, Talamo RC. Unilateral hyperlucent lung (Swyer-James syndrome) after severe Mycoplasma pneumoniae infection. The American Review of Respiratory Disease. 1978;117(1): 145–152.
- Trimis G, Theodoridou M, Mostrou G, Kakavakis K. Swyer-James (MacLeod’s) syndrome following pertussis infection in an infant. Scandinavian Journal of Infectious Diseases. 2003;35(3): 197–199.
- Khalil KF, Saeed W. Swyer-James-MacLeod syndrome. Journal of College of Physicians and Surgeons Pakistan. 2008;18(3): 190–192.
- Gopinath A, Strigun D, Banyopadhyay T. Swyer-James syndrome. Connecticut Medicine. 2005;69(6): 325–327.
- Hamada S, Tsukino M. Swyer-James-Macleod syndrome: the differential diagnosis of unilateral hyperlucency. Journal of Internal Medicine. 2018;57(17): 2591–2592.
- Reid L, Simon G. Unilateral lung transradiancy. Thorax. 1962;17: 230–239.
- Chen IC, Chen YW, Lin SH, Hsu JH, Wu JR, Dai ZK. Usefulness of combination of pulmonary ventilation and perfusion scintigraphy on the diagnosis of children with unilateral hyper-lucent lung. Nuclear Medicine Communications. 2011;32(11): 1052–1059.
- Quaedvlieg V, Duysinx B, Ghaye B, Bartsch P. [Clinical case of the month. MacLeod syndrome]. Revue Médicale De Liège. 2004;59(12): 691–694.
- Daniel TL, Woodring JH, Vandiviere HM, Wilson HD. Swyer-James syndrome – unilateral hyperlucent lung syndrome. A case report and review. Clinical Pediatrics. 1984;23(7): 393–397.
- Chaucer B, Chevenon M, Toro C, Lemma T, Grageda M. Swyer-James-Macleod syndrome: a rare finding and important differential in the ED setting. The American Journal of Emergency Medicine. 2016;34(7): 1329.e3-4.
- DeviceMed-Septembre-Octobre-2018, le magazine des fabricants de dispositifs medicaux, ISSN 2198-3410 Euro 11, Pg. 35.
- PhysioAssist, SIMEOX manuel user, 31 Parc du Golf - CS 90519 13593 Aix-en-provence Cedex 3 France. CE certificate No. 30493 of 10/01/2019, www.physioassist.com pg 3 – 7.
- Manuel physioassist, Breathe again ! innovation in airway clearance, 31 Parc du Golf - CS 90519 13593 Aix-en-provence Cedex 3 France. CE certificate No. 30493 2019, https://pdf.medicalexpo.com/pdf/physio-assist-sas/breathe-again/120425-231912.html Pg 3.
- Lafforgue O, Seyssiecq I, Poncet S, Favier J. Rheological properties of synthetic mucus for airway clearance. Journal of Biomedical Materials Research Part A. 2018;106(2): 386–396.
- Lafforgue O, Bouguerra N, Poncet S, Seyssiecq I, Favier J, Elkoun S. Thermo-physical properties of synthetic mucus for the study of airway clearance. Journal of Biomedical Materials Research Part A. 2017;105: 3025–3033.
- Simeox Clinical Notebook No. 4: European Virtual Roundtables on Simeox Therapy. “Experience in clinical practice with the use of Simeox therapy at each stage of the care of the CF patient”, Preparation of the presentation of cases and discussion: Dr. Justyna Milczewska.
- Short-term effects of a novel bronchial drainage device in cystic fibrosis patients, Department of Pediatric and Adolescent Medicine, Ulm University Medical Center 2 Institute of General Physiology, Ulm University 2021, Germany.
- Preliminary data on the effects of Simeox therapy in post-Covid 19 patients referred to pulmonary rehabilitation - Retrospective data collection Pr. Jan Szczegielniak, Ministry of Internal Affairs and Administration Specialist Hospital. Glucholazy, Poland. 2021.
- Mihaltan F, Morin L, Borcea C, Costantin A, Pahontu A, Marinescu L, et al. Effects of a new airway clearance technology versus manual physiotherapy in COPD. European Respiratory Journal. 2018;52(Supplement 62): PA4047.
- Rapport de l’étude clinique SIMETOL, Février 2019.
- Revue des Maladies Respiratoires, Volume 36, Supplément, 2019, Évaluation d’une nouvelle technologie de drainage bronchique versus kinésithérapie manuelle dans la bronchopneumopathie chronique obstructive (BPCO) P. A65-A66 - janvier 2019 par Elsevier Masson SAS. https://www.em-consulte.com/article/1267389/evaluation-d-une-nouvelle-technologie-de-drainage.
- Simeox therapy in patients with CORPD and Asthma, national institute for TB, lung diseases and thoracic surge, Ivan Solovic, Alena Bdodnarova, Vysne Hagy, Slovakia. Solovisc polish Congres 2018 ppt.